Roberto Garofalo, MD, is a Professor in the Division of Immunology/Allergy/Rheumatology, Department of Pediatrics, University of Texas Medical Branch. Dr. Garofalo is also a faculty member of the Graduate School Program in Microbiology & Immunology and serves as Established Investigator for the NIHCD-funded Child Health Research Center in Developmental Immunobiology and for the NIEHS Center in Environmental Toxicology at UTMB. Dr. Garofalo's research interest is the ontogeny, function, and regulation of the mucosal immune system. Specifically, areas of his investigations include pathogenesis of respiratory syncytial virus (RSV) infection; experimental therapy and vaccine development for RSV; role of viral infections in allergic sensitization and asthma development; transcriptional regulation of inflammatory genes in the airway mucosa; molecular and functional characterization of immunomodulatory substances in human milk and interaction of these with the infant mucosal system. Dr. Garofalo's laboratory is currently funded by federal grants and other extramural and UTMB grants. Dr. Garofalo is also the Project Leader and Director of the Tissue Culture and Immunoassay Core of the newly established asthma and allergic disease Research Center at UTMB, funded by the NIH. Dr. Garofalo is a member of the American Association of Immunologists, Society for Pediatric Research, Society of Mucosal Immunology, European Society for Pediatric Infectious Disease, European Society for Pediatric Hematology and Immunology, International Society for research in Human Milk and Lactation.